节点文献

缬沙坦对心力衰竭患者心律失常的影响研究

The effect of valsartan on arrhythmias in chronic heart failure

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 毕亚艳朴晶燕李智博黄永麟

【Author】 BI Ya-yan,PIAO Jing-yan,LI Zhi-bo,HUANG Yong-lin.Deparment of Cardiology,the First Affiliated Hospital of Harbin Medical University,Harbin 150001,China

【机构】 哈尔滨医科大学第一临床医学院心内科汕头大学医学院附属第一医院

【摘要】 目的探讨慢性心力衰竭患者缬沙坦治疗后,血浆镁浓度(PMC)、红细胞镁含量(EMC)和红细胞Na+/Mg2+交换速率与心律失常的相关性。方法收集2006年3月至2007年3月哈尔滨医科大学第一临床医学院心内科128例充血性心力衰竭病例并随机分为两组,常规治疗加缬沙坦组(观察组)和不加缬沙坦组(对照组),采用原子吸收光谱火焰法测定两组治疗前、治疗6个月后PMC、EMC以及Na+/Mg2+交换速率,以Holter检测两组治疗6个月时心律失常发生情况。结果(1)治疗前两组PMC、EMC、VTmax(红细胞总镁外流量最大速度)、VNImax(红细胞非钠依赖性镁外流最大速度)、VNDmax(红细胞钠依赖性镁外流最大速度)比较差异无统计学意义(P>0.05)。(2)治疗6个月后,观察组PMC、EMC与对照组比较差异均有统计学意义(P<0.05,P<0.01);观察组VNImax与对照组比较差异无统计学意义(P>0.05);观察组VTmax、VNDmax与对照组比较均明显降低,差异均有统计学意义(P<0.01)。(3)两组治疗6个月后,观察组各种心律失常的发生较对照组显著减少。结论(1)心衰治疗加缬沙坦后,Na+/Mg2+交换速率降低,PMC与EMC增加,并由此减少了各种心律失常的发生。(2)缬沙坦的抗心律失常作用可能与增加了细胞的Mg2+稳态有关。

【Abstract】 Objective To explore plasma magnesium concentration(PMC),erythrocyte magnesium content(EMC),erythrocyte Na+/Mg2+exchange rate and arrhythmia in patients with chronic heart failure with or without valsartan treatment.Methods A total of 128 patients with chronic heart failure were randomly divided into two groups.Group one:standard treatment with valsartan therapy;group two:standand treatment without valsartan therapy.Plasma magnesium concentration(PMC),erythrocyte magnesium content(EMC)and Na+/Mg2+exchange rate were measured by flame assay of atomic absorption spectrophotometer before treatment and after 6 months’ treatment.The 24 h-Holter was observed for arrhythmias in the two groups after 6 months’ treatment.Results (1)There was no significant difference in PMC,EMC,VTmax,VNImax,VNDmax between the two groups(P>0.05)before treatment.(2)After 6 months’ treatment,there was significant difference in PMC and EMC(P<0.05,P<0.01) and no significant difference in VNImax between the two groups(P>0.05).VNDmax and VTmax were significantly lower in group one than in group two(P<0.01).(3)The arrhythmia occurrence in group one was lower than that in group two after 6 months’ therapy.Conclusion (1)Decreased VNDmax caused by inhibition of Na+/Mg2+exchange rate in patients with chronic heart failure treated by Valsartan may inhibit the occurrence of arrhythmias.(2)The anti-arrhythmia action of valsartan may relate to enhancing magnesium stability in myocardial cells.

【关键词】 心力衰竭心律失常缬沙坦离子交换
【Key words】 heart failurearrhythmiavalsartanion exchange
  • 【文献出处】 中国实用内科杂志 ,Chinese Journal of Practical Internal Medicine , 编辑部邮箱 ,2008年09期
  • 【分类号】R541.6;R541.7
  • 【被引频次】2
  • 【下载频次】65
节点文献中: 

本文链接的文献网络图示:

本文的引文网络